# Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis

> **NCT03163420** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 68 (estimated)

## Conditions studied

- Irreversible Pulpitis

## Interventions

- **DRUG:** Diclofenac potassium
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03163420
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163420, "Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03163420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*